Diabetic Polyneuropathy: Micronutrient Therapy

An at-risk group indicates the possibility that the disease may be associated with the risk of vital nutrient deficiency. The complaint diabetic polyneuropathy indicates a vital nutrient deficiency for

  • L-carnitine

Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for prevention.

  • Omega-6 fatty acid gamma-linolenic acid

Within the framework of micronutrient medicine, the following vital substances (micronutrients) are used for supportive therapy.

  • Vitamin B12
  • Zinc
  • Omega-6 fatty acid gamma-linolenic acid
  • Alpha lipoic acid